Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("SCHECHTER, P. J")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 41

  • Page / 2

Export

Selection :

  • and

Chemotherapeutic implications of polyamine biosynthesis inhibitionSJOERDSMA, A; SCHECHTER, P. J.Clinical pharmacology and therapeutics. 1984, Vol 35, Num 3, pp 287-300, issn 0009-9236Article

Clinical relevance of measuring GABA concentrations in cerebrospinal fluidSCHECHTER, P. J; SJOERDSMA, A.Neurochemical research. 1990, Vol 15, Num 4, pp 419-423, issn 0364-3190, 5 p.Article

Difluoromethylornithine in the treatment of African trypanosomiasisSCHECHTER, P. J; SJOERDSMA, A.Parasitology today (Regular ed.). 1986, Vol 2, Num 8, pp 223-224, issn 0169-4758Article

Topical nanocrystalline silver cream suppresses inflammatory cytokines and induces apoptosis of inflammatory cells in a murine model of allergic contact dermatitisBHOL, K. C; SCHECHTER, P. J.British journal of dermatology (1951). 2005, Vol 152, Num 6, pp 1235-1242, issn 0007-0963, 8 p.Article

Traitement de la tryapnosomiase humaine à Trypanosoma brucei brucei gambiense par l'alpha-difluorométhylornithine: résultats chez 7 patients = Treatment of human T.b.g. infection by α difluoromethylornithine. Results of 7 patientsTAELMAN, H; MARCELIS, L; SONNET, J et al.Bulletin de la Société de pathologie exotique. 1988, Vol 81, Num 3, pp 578-588, issn 0037-9085Conference Paper

Double-blind, placebo-controlled study of vigabratin (Gamma-vinyl GABA) in drug-resistant epilepsyLOISEAU, P; HARDENBERG, J. P; PESTRE, M et al.Epilepsia (Copenhagen). 1986, Vol 27, Num 2, pp 115-120, issn 0013-9580Article

Kinetics of fenoximone, a new cardiotonic, in healthy subjectsALKEN, R. G; BELZ, G. G; HAEGELE, K. D et al.Clinical pharmacology and therapeutics. 1984, Vol 36, Num 2, pp 209-216, issn 0009-9236Article

Pharmacokinetics and tolerability of intravenous trecovirsen (GEM®91), an antisense phosphorothioate oligonucleotide, in HIV-positive subjectsSERENI, D; TUBIANA, R; GOUYETTE, A et al.Journal of clinical pharmacology. 1999, Vol 39, Num 1, pp 47-54, issn 0091-2700Article

Review : normal and abnormal central nervous system GABA metabolism in childhoodJAEKEN, J; CASAER, P; HAEGELE, K. D et al.Journal of inherited metabolic disease. 1990, Vol 13, Num 6, pp 793-801, issn 0141-8955, 9 p.Article

L'alpha-difluorométhylornithine (eflornithine) dans le traitement de la trypanosomiase humaine africaine à T. gambiense au stade tardif: efficacité et tolérance. A propos de 14 cas = The α difluoromethylornithine (eflornithine) in the treatment of human african trypanosomiasis due to T. g. at the late state. Efficacity and toleranceDOUA, F; BOA, F. Y; SCHECHTER, P. J et al.Bulletin de la Société de pathologie exotique. 1988, Vol 81, Num 3, pp 589-590, issn 0037-9085Conference Paper

Decarboxylated-S-adenosylmethionine excretion: a biochemical marker of ornithine decarboxykase inhibition by α-difluoromethylornithineHAEGELE, K. D; SPLINTER, T. A. W; ROMIJN, J. C et al.Cancer research (Baltimore). 1987, Vol 47, Num 3, pp 890-895, issn 0008-5472Article

Gamma-aminobutyric acid-transaminase deficiency: a newly recognized inborn error of neurotransmitter metabolismJAEKEN, J; CASAER, P; DE COCK, P et al.Neuropediatrics. 1984, Vol 15, Num 3, pp 165-169, issn 0174-304XArticle

Essai de traitement de la trypanosomiase à Trypanosoma brucei-gambiense par l'eflornithine en République Populaire du Congo = Clinical trial of eflornithine in human T.b.g. trypanosomiasis in the CongoEOZENOU, P; JANNIN, J; NGAMPO, S et al.Médecine tropicale. 1989, Vol 49, Num 2, pp 149-154, issn 0025-682XArticle

Trypanosomiase africaine de l'enfant traitée par éflornithine. Un cas = Childhood African trypanosomiasis treated with eflornithineBENHAMOU, P. H; CHANDENIER, J; SCHECHTER, P. J et al.La Presse médicale (1983). 1989, Vol 18, Num 24, pp 1199-1202, issn 0755-4982Article

Treatment of human late stage gambiense trypanosomiasis with α-difluoromethylornithine (eflornithine): efficacy and tolerance in 14 cases in Côte d'IvoireDOUA, F; BOA, F. Y; SCHECHTER, P. J et al.The American journal of tropical medicine and hygiene. 1987, Vol 37, Num 3, pp 525-533, issn 0002-9637Article

Double-blind study of oral γ-vinyl GABA in the treatment of dystoniaCARELLA, F; GIROTTI, F; SCIGLIANO, G et al.Neurology. 1986, Vol 36, Num 1, pp 98-100, issn 0028-3878Article

Kinetics of medroxalol, a β- and α-adrenoceptor antagonistHAEGELE, K. D; JAILLON, P; CHEYMOL, G et al.Clinical pharmacology and therapeutics. 1983, Vol 34, Num 6, pp 785-791, issn 0009-9236Article

Pharmacokinetics of anti-human immunodeficiency virus antisense oligodeoxynucleotide phosphorothioate (GEM 91) in HIV-infected subjectsRUIWEN ZHANG; JIEMING YAN; SCHECHTER, P. J et al.Clinical pharmacology and therapeutics. 1995, Vol 58, Num 1, pp 44-53, issn 0009-9236Article

Cerebrospinal fluid parameters in healthy volunteers during serial lumbar puncturesBEN MENACHEM, E; PERSSON, L; SCHECHTER, P. J et al.Journal of neurochemistry. 1989, Vol 52, Num 2, pp 632-635, issn 0022-3042, 4 p.Article

A propos d'un cas de trypanosomiase africaine traitée en France par l'eflornithine = One case of african trypanosomiasis treated in France with eflornithineCHANDENIER, J; BENHAMOU, P. H; SCHECHTER, P. J et al.Bulletin de la Société française de parasitologie. 1988, Vol 6, Num 1, pp 7-10, issn 0761-8328Article

2-pyrrolidinone in human cerebrospinal fluid: a major constituent of total γ-aminobutyric acidHAEGELE, K. D; SCHWARTZ, J.-J; SCHOUN, J et al.Journal of neurochemistry. 1987, Vol 49, Num 5, pp 1402-1406, issn 0022-3042Article

Treatment of acute myeloid leukemia and blastic phase of chronic myeloid leukemia with combined eflornithine-alpha difluoromethylornithine and methylglyoxal-bis-guanyl hydrazone (methyl-GAG)GASTAUT, J.-A; TELL, G; SCHECHTER, P. J et al.Cancer chemotherapy and pharmacology. 1987, Vol 20, Num 4, pp 344-348, issn 0344-5704Article

Treatment of gambiense sleeping sickness in the Sudan with oral DFMO (DL-α-difluoromethylornithine), an inhibitor of ornithine decarboxylase; first field trialVAN NIEUWENHOVE, S; SCHECHTER, P. J; DECLERCQ, J et al.Transactions of the Royal Society of Tropical Medicine and Hygiene. 1985, Vol 79, Num 5, pp 692-698, issn 0035-9203Article

Effects du gamma-vinyl GABA per os dans cinq cas de schizophrénie hébéphréno-catatonique = Effects of oral gamma-vinyl GABA in five cases of hebephreno-catatonic schizophreniaLAMBERT, P. A; CHABANNES, J. P; CANTINIAUX, P et al.L' Encéphale (Paris). 1983, Vol 9, Num 2, pp 145-149, issn 0013-7006Article

Anti-inflammatory effect of topical nanocrystalline silver cream on allergic contact dermatitis in a guinea pig modelBHOL, K. C; ALROY, J; SCHECHTER, P. J et al.Clinical and experimental dermatology (Print). 2004, Vol 29, Num 3, pp 282-287, issn 0307-6938, 6 p.Article

  • Page / 2